Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 10, 2010
Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guidelineBrendan J W Miles, Adrian S Fairey, Michael Eliasziw, et al.Investigational New Drugs|March 13, 2015
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumorsQuincy Siu-Chung Chu, Randeep Sangha, Jennifer Spratlin, et al.Journal of the National Cancer Institute|October 3, 2002
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinomaFred Saad, Donald M Gleason, Robin Murray, et al.Journal of the National Cancer Institute|June 3, 2004
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancerFred Saad, Donald M Gleason, Robin Murray, et al.Cureus|April 16, 2016
Avascular Necrosis of the Femoral Head After Palliative Radiotherapy in Metastatic Prostate Cancer: Absence of a Dose Threshold?Alia M Daoud, Mack Hudson, Kenneth G Magnus, et al.The Journal of Urology|September 18, 2007
Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941Bernard Escudier, Toni K Choueiri, Stéphane Oudard, et al.Cancer|April 23, 2008
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trialTomasz M Beer, Alshad S Lalani, Stella Lee, et al.BMJ Open|October 17, 2020
Cohort profile: the Alberta Prostate Cancer Research Initiative (APCaRI) Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, CanadaCatalina Vasquez, Michael Kolinsky, Rume Djebah, et al.Journal of Oncology Practice|August 15, 2013
Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinomaLori Wood, Georg A Bjarnason, Peter C Black, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 19, 2017
First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experienceAly-Khan A Lalani, Haocheng Li, Daniel Y C Heng, et al.Pageof 3